7 Business Lessons From The Failed Daiichi–Ranbaxy deal - Strategy With RS
The Daiichi – Ranbaxy deal has once again grabbed headlines. Malvinder and Shivinder Singh, the former owners of Ranbaxy Laboratories, were ordered by a Singapore arbitration tribunal to pay $385 million to Japanese pharma company Daiichi Sankyo, which had bought the firm in 2008. Daiichi has accused the brothers of misrepresenting the problems facing Ranbaxy when it acquired the firm.






